#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic inflammatory myopathy Marfan's syndrome Hypochromic anaemia Heart disease congenital Astrocytoma Immunoglobulin G4 related disease Glomerulonephritis Hyperinsulinism Deafness Endometrial cancer Fibrodysplasia ossificans progressiva Cervix carcinoma Lymphangioma Primary biliary cholangitis Bronchiolitis More trials…

    Learn about Rare Diseases

    Amyotrophic lateral sclerosis – Treatment Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Chondrosarcoma – Diagnostics Ocular melanoma – Life with Disease SAPHO syndrome – Basic Information Indolent systemic mastocytosis – Basic Information Glomerulonephritis membranous – Basic Information Congenital generalised lipodystrophy – Treatment Mucous membrane pemphigoid – Treatment Prolymphocytic leukaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Resmetirom Pseudoephedrine Hydrochloride Ranolazine Bexotegrast Tamibarotene Insulin Icodec TORASEMIDE Toldc Metoprolol 13N-AMMONIA Dirocaftor Tropicamide Ly3437943 Sodium Fosaprepitant Abiraterone Acetate Enx-101 Lonapegsomatropin Phenylalanine Incb099280 Barium Sulfate More therapies…

    Learn about Your Condition

    Monkeypox Behcet's syndrome Rhabdoid tumour Cervix carcinoma stage II Post-traumatic stress disorder Chorioretinitis Tendon disorder Mucous membrane pemphigoid Lichen sclerosus Death neonatal EGFR gene mutation Drug dependence Ovarian granulosa cell tumour Paedophilia Tumour of ampulla of Vater More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study testing gene therapy with Dream01 and imatinib for patients with severe sickle cell disease to improve red blood cell production

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Imatinib
    France

  • Testing zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Durvalumab
    • Nivolumab
    Austria Belgium Denmark France Germany Greece +6

  • A Study of Belumosudil for Patients with Steroid-Resistant Overlap Syndrome Graft-versus-Host Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Belumosudil Mesilate
    Germany

  • Study of melphalan followed by eribulin, vinorelbine, or capecitabine versus eribulin, vinorelbine, or capecitabine alone for metastatic breast cancer patients with liver disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Melphalan
    • Vinorelbine Tartrate
    • Capecitabine
    France Germany Italy Spain Sweden

  • Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Sotatercept
    Belgium Croatia Czechia Denmark France Germany +7

  • A Study of BCX17725 Safety and Effects in Healthy People and Patients with Netherton Syndrome

    Recruiting

    1 1 1
    France Germany The Netherlands
Previous Page
1 … 90 91 92 93 94 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!